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The neuropeptide oxytocin (OT) has been shown to enhance dogs’ ability to perform an
object choice task (OCT) involving the use of human pointing cues, when delivered
intranasally. This study aimed at further investigating whether OT enhances task
performance by increasing choices made, or by increasing correctness of choices
made, and to compare these treatment effects to dog appeasing pheromone (DAP),
known to balance emotional activation in dogs. Hence, we compared OCT performance
between three groups of dogs: (i) dogs administered OT and a sham collar, (ii) dogs
administered a saline placebo and a DAP collar, and (iii) control dogs administered a
saline placebo and a sham collar. All three groups consisted of a combination of male
and female pet dogs and assistance-dogs-in-training currently living with a volunteer
carer. The study also evaluated the effect of intranasal OT and/or DAP on plasma
levels of OT, and prolactin; which has previously been linked with anxiety in dogs.
The dogs’ emotional state was measured using the Emotional Disorders Evaluation
in Dogs (EDED) scale. The owners’/carers’ degree of anxious- and avoidant-style
attachment to their dogs was accessed using the Pet Attachment Questionnaire (PAQ).
Interesting descriptive data appeared for both treatment groups. Particularly, in OT
group, we obtained significant results demonstrating that intranasal OT enhances OCT
performance in dogs compared to control, by increasing the percentage of correct
choices, but not the number of choices, made. Results also support that the mode
of action of intranasal OT is via direct access to the brain and not via the blood,
since no elevation of plasma OT (or prolactin) levels were observed after intranasal
administration in this study. Similarly, DAP application did not significantly alter OT
or prolactin peripheral concentrations. Several differences were observed between
fostered and pet dogs, namely: fostered dogs demonstrated higher levels of serum
prolactin, made more choices on the OCT compared to pet dogs but were not more
likely to be correct, and were fostered by carers with higher avoidant attachment scores
than pet dog owners. These findings implicate consideration of potential carer and
training consequences for assistance dogs.
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INTRODUCTION
Dogs have remarkable abilities to communicate with humans
(Hare and Tomasello, 2005), and we now specifically breed dogs
for the unique purpose of placing them in working roles that
assist humans. Nowadays, dogs are used by humans for various
working roles, including assisting, guiding, herding, detecting,
racing, and guarding (Cobb et al., 2015). The ability of dogs to
successfully work in these roles is dependent on a wide variety of
factors depending on the job, but for assistance (guiding, hearing,
and service) dogs (for definition see, Bremhorst et al., 2018), this
includes their ability to cope in stressful situations, and to form
affiliative bonds with their human counterparts. This is no small
feat as it is often necessary for these dogs to forge several human
relationships over their lifetime, each time detaching from the
previous to allow the new relationship to form. If they turn out
to be mismatched to their handler, they can be re-homed up
to eight times (Lloyd et al., 2016) and must detach and attach
every time. Cobb et al. (2015) has estimated the current rate
of success across a variety of trained working dogs to be only
around 50%. The total cost of a guide dog’s 8-year working life
has been estimated to be US$40,598 with the majority of these
costs (US$34,972) incurred by the training school during the
dog’s first year of life (Wirth and Rein, 2008). Hence, research
to close this gap between steep costs and low success rates is
clearly warranted.
Dog-human attachment should not be considered in one
direction only – the ability of humans to attach to a working
dog is also very important to consider. Following the work
of Ainsworth et al. (1978) who classified human infants as
securely, anxiously or avoidantly attached to their primary
caregiver, Zilcha-Mano et al. (2011) found that these styles
of attachment can also be applied to the way in which adult
owners attach to their pets. The fact that assistance dogs are
raised by volunteer carers who inevitably must give them
back to the assistance dog association in which they were
born may cause carers to form more insecure (anxious and/or
avoidant) attachments with the dogs they care for, compared
to companion dog owners. Avoidant adult attachment styles
have been associated with owning dogs with separation-related
disorders (Konok et al., 2015), and this could be quite problematic
in a foster care situation where there would be an even
greater need for the carer to guard against an inevitable loss.
While previous work by Mariti et al. (2013) showed that there
was no difference in behaviors indicating an attachment bond
between pets and search-and-rescue dogs who live with their
“handlers,” these differences have not been investigated in pets
versus fostered dogs.
Insecure attachments have been shown to impact dogs’ ability
to use human social gestures. For example, Oliva et al. (2016a)
showed that owners who scored high for anxious attachments
to their dogs, according to the Pet Attachment Questionnaire
(PAQ) (Zilcha-Mano et al., 2011), owned dogs that were more
likely to perform poorer on an object choice task (OCT) in which
pointing cues were used to indicate the location of a hidden food
reward. For dogs whose job requires the use of human pointing
gestures or the ability to read human non-verbal communication
in general, this could be a critical problem. Interestingly, this
relationship disappeared following the intranasal administration
of synthetic oxytocin (OT) (Oliva et al., 2016a). Oxytocin is
known for its role in mammalian bonding (for a review see,
Lim and Young, 2006) and social cognition in humans (for a
review see, Bartz et al., 2011). In dogs, intranasally applied OT
has been shown to increase positive expectations (Kis et al.,
2015), decrease friendliness in response to a threatening person
(Hernádi et al., 2015), increase affiliation toward owners and
conspecifics (Romero et al., 2014), increase play behaviors toward
conspecifics (Romero et al., 2015) and increase mutual gaze
with their owners (Nagasawa et al., 2015). It has also been
found to enhance performance on OCTs (Oliva et al., 2015;
Macchitella et al., 2017). It remains unknown exactly how
and where OT exerts its OCT-enhancing effects. With regards
to “how,” two possibilities exist. The first is that OT directly
improves social cognitive function, and the second is that it
indirectly enhances cognitive function by modulating emotions
which may be inhibiting social cognition. Indeed, in humans, OT
has been shown to have anxiolytic properties (Heinrichs et al.,
2003; de Oliveira et al., 2012). With regards to “where,” it has
long been believed that intranasally administered peptides gain
access to the brain as increased levels of the peptide can be
measured in cerebrospinal fluid (CSF) following administration
(Born et al., 2002; Gossen et al., 2012; Neumann et al., 2013;
Striepens et al., 2013; Dal Monte et al., 2014; Freeman et al.,
2016; Rault, 2016; Lee et al., 2018). However, as discussed in their
review, Leng and Ludwig (2016) explain that the increases in
CSF are only modest in comparison to the amount administered.
However, the authors also acknowledge that central OT may
be largely degraded in brain tissue and therefore only enter
the CSF in minimal amounts. Nevertheless, the relatively large
rise in peripheral measures that sometimes follows intranasal
application has cast doubt in these researchers’ minds that the
administered peptide is primarily acting at the level of the
brain (Leng and Ludwig, 2016). Furthermore, it has recently
been suggested that the neuro-behavioral effects of intranasally
administered OT may stem from a peripheral mechanism of
action, following results from a study by Lee et al. (2018)
which demonstrated highly variable timings and extents that
both intranasally and intravenously administered OT reached
the CSF of monkeys. Temesi et al. (2017) and Romero et al.
(2014) also demonstrated an increase in OT measured in dog
blood following intranasal application, however, as these studies
used varying methods, doses, and small sample sizes, the current
study will extend upon these findings in a larger sample of dogs
using recently validated methods (Bienboire-Frosini et al., 2017;
MacLean et al., 2017), as stated hereunder in the “Materials and
Methods” section.
Unfortunately, central OT function is difficult to measure
in a minimally invasive way. Indeed, OT is produced in the
hypothalamus and released from magnocellular neurons that
project to the posterior lobe of the pituitary where it is
naturally secreted into the bloodstream and acts as a hormone
(Lim and Young, 2006). Oxytocin is also directly secreted
into central brain regions from hypothalamic magnocellular
neurons (Knobloch et al., 2012) which also release the peptide
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into the CSF from their somas and dendrites, where it has
the potential to act as a kind of slower-acting and longer-
lasting “hormone” in the central nervous system (Ludwig
and Leng, 2006). Extrapolating from peripheral measures is
problematic because the central and peripheral release of OT
from magnocellular neurons of the hypothalamus are not
necessarily time-locked; OT can be released independently at
different neuronal sites, in response to the same stimulus. Indeed,
there are reports of dendritic release being delayed by more than
1 h, compared to the more immediate release at the terminal
bouton, and exerting its effects for much longer (Ludwig and
Leng, 2006). Furthermore, certain social stressors in rats have
been shown to induce central, but not peripheral secretion
(Engelmann et al., 1999). Conversely, studies in guinea pigs
show that peripheral OT increases in response to suckling,
without an accompanying increase in the CSF [measured
by immunoassay with prior solid phase extraction (Amico
et al., 1990) and High-Performance Liquid Chromatography
(Robinson and Jones, 1982)]. As neuropeptides do not readily
pass the blood–brain barrier (Vorherr et al., 1968; Mens et al.,
1983; Robinson, 1983; Veening et al., 2010), it follows that levels
in the brain and in the blood may be substantially different
at any one time.
Thus, while extrapolating from peripheral measures to draw
conclusions about real-time central OT function is dubious,
peripheral levels of the peptide may be a possible reflection of the
overall functioning of the oxytocinergic system of the organism.
For example, in humans, plasma OT is positively associated with
number of attachment figures (Jobst et al., 2014) and tendency
to be emotionally open (Tops et al., 2007). For this reason, we
are interested in investigating the association between plasma
levels of OT and OCT performance in dogs, and the influence
of intranasally administered OT, in the current study. We are
also interested in measuring serum prolactin, firstly because
its release can be stimulated by OT, for example in response
to suckling, mating and ovarian steroids (Kennett and McKee,
2012), but also because it is released in response to situational
stressors in humans (Jeffcoate et al., 1986; Armario et al., 1996)
and rats (Torner and Neumann, 2002; Torner et al., 2004). In
addition, serum prolactin has been associated with scores on
the Emotional Disorders Evaluation in Dogs (EDED; Pageat,
1995) scale in a sample of anxious dogs (Pageat et al., 2007).
The EDED assesses behaviors and physiologies of dogs that are
modified by emotional disorders and scores them according
to their severity.
An alternative method to potentially activate central OT is
via the administration of pheromones believed to involve the
release of OT in the brains of mammals (see reviews, Bielsky and
Young, 2004; Wacker and Ludwig, 2012). In dogs, a synthetic
analog of the natural maternal appeasing pheromone, known
as dog appeasing pheromone (DAP) (ADAPTIL R©; Ceva Santé
Animale), which is naturally released by bitches to appease their
young, has been identified. Processing of pheromones occurs
within the medial amygdala (Salazar and Sànchez Quintero,
2009) and is likely to integrate information coming from both
the main olfactory bulb and the accessory olfactory bulb, where
OT receptors have been reported (Wacker and Ludwig, 2012).
Behavioral effects of DAP are not dissimilar to the behavioral
effects following intranasal OT administration. For example,
studies have shown that DAP reduces behavioral indicators of
stress in a shelter (Tod et al., 2005), owner-reported fear of
fireworks (Sheppard and Mills, 2003) and fear and anxiety scores
in response to a thunderstorm recording (Landsberg et al., 2015).
It also alleviates behavioral and neuroendocrine perioperative
stress responses (Siracusa et al., 2010) and increases relaxation
and reduces anxiety (but not aggression) in a veterinary clinic
(Mills et al., 2006). It has also been shown to reduce stress-
related behaviors (Gaultier et al., 2008) and fear of novel
people (Gaultier et al., 2009) in recently adopted puppies.
Furthermore, there is evidence that DAP reduces undesirable
behaviors related to dogs’ separation from their owners, with a
similar efficacy as using the psychotropic drug, clomipramine
(Gaultier et al., 2005). In addition, it reduces separation-related
anxiety signs during hospitalization (Kim et al., 2010), and
reduces fear and anxiety in puppies during training and enhances
socialization up to 1 year later (Denenberg and Landsberg,
2008). There are currently no known studies of the efficacy
of DAP in enhancing “following” behaviors in response to
human social cues or blood measures of OT or prolactin
related to DAP use.
If both DAP and intranasally administered OT lead to
increased levels of OT in the brain, exposure to both DAP
and OT intranasal administration could have similar effects
on consequent measures of blood neuro-hormone levels, and
possibly on OCT performance. Hence, the aim of this study was
to (i) compare the enhancing effects of DAP and intranasally
administered OT on plasma levels of OT, and prolactin, and
dogs’ OCT performance, against control and (ii) to explore
the predictive power of: dog gender (as Oliva et al. (2015)
demonstrated that male dogs perform better on the OCT after
saline, but females respond more to the oxytocin intranasal
treatment), origin (pet or foster dog), dog weight, home
location (inside/outside – ambient temperature is known to
influence levels of prolactin in the body, which may have
flow on effects for the individual (see review, Alamer, 2011),
point-following ability (spontaneous/non-spontaneous – refer
to Materials and Methods section), plasma OT levels, serum
prolactin levels, owner avoidant attachment scores, owner
anxious attachment scores, EDED scores, and treatment, on OCT
performance. Finally, the study aimed to identify differences
in pet owner versus puppy carer attachment, as well as pet
versus foster dog prolactin levels. It was hypothesized that,
(i) plasma levels of OT will increase and serum levels of
prolactin will decrease following DAP and OT exposure and
that OCT performance will be enhanced by both OT and
DAP compared to placebo. We also expected (ii) higher
levels of plasma OT to be present in better performing dogs
and better performing dogs to be more likely to be male
and to be pets, while higher EDED scores and levels of
prolactin to be present in poorer performing dogs. Lastly, we
expected that foster owners would demonstrate greater avoidant
attachment toward their dogs compared to pet owners and
that foster dogs would have higher levels of serum prolactin
compared to pet dogs.
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MATERIALS AND METHODS
Animals
A sample of 51 dogs and their owners or volunteer carers were
recruited for the study. All dogs were more than 10 months old
and recruited from either the assistance dogs association, Frédéric
Gaillanne Foundation (FGF), or from owners that heard about
the study via word of mouth, poster advertisements in pet shops,
groomers or on the social media website, Facebook. Dogs who,
at physical examination, were found to be pregnant, lactating,
sensory impaired, or less than 2 kg were not included in the
study. All entire females were tested on the OCT at least 2 months
out of estrus. All dogs recruited from the FGF were in training
and still living part time with the same human carer who had
been assisting the FGF to raise them since they were between
8 and 10 weeks old. Henceforth these dogs shall be referred to
as “foster dogs” and their volunteer carers as “puppy carers.”
Dogs were to be excluded from the study if they showed signs
of physical illness or extreme social phobia or aggression. The
assessment of the dogs’ emotional status according to the EDED
(refer to Materials section) scale did not reveal any emotional
disorders which could have resulted in a non-inclusion. All dogs
fell into the “normal” range, except for two pet dogs allocated
to the DAP treatment group who fell into the “phobic” range.
One foster dog was found to be pregnant at examination and
was thus not included in the study. Two pet dogs displayed
aggression in session 1 and were thus excluded. Two additional
foster dogs changed puppy carers between sessions and were
also excluded, thereby leaving a final sample of 46 dogs, 25
pets [17 Males (4 entire), 8 Females (2 entire)] and 21 foster
dogs [9 Males (0 entire), 12 Females (2 entire)]. Tables 1
and 2 show details of the population involved in the study. The
study was approved by the IRSEA Ethics Committee, approval
number AFCE_201605_02.
Materials
Twenty-four international units of OT (Sigma, St Quentin
Fallavier, France) diluted in 0.2 ml of 0.09% saline, or 0.2 ml
of 0.09% saline only (acting as a control) were administered
to the nostrils of each dog, with a half-dose in each nostril.
Treatments were delivered using a Mucosal Atomizer Device
(Teleflex Medical SAS, La Pousaraque, France) connected to a
1 mL syringe. Treatments were prepared by a team member who
did not take part in the experimental testing and were labeled
as “A” or “B” to ensure that the researchers involved in the
experiment were “blind” to the treatment conditions.
Adaptil R© collars impregnated with DAP or identical collars
without impregnated DAP (placebo) provided by Ceva Santé
Animale (Libourne, France), were fitted to the dogs’ neck in
order to continuously expose dogs to DAP or placebo. Dogs
were wearing the collar at least 1 day (24 h) before the OCT.
Collars were also labeled as “A” or “B” by the same team member
who did not take part in the experimental testing to ensure that
the researchers involved in the experiment were “blind” to the
treatment conditions. According to the combination of double-
blinded intranasal and collar treatments that the dog received, it
belonged to a treatment group called “A,” “B” or “C,” which the
experimenters were completely blinded to as well, until after the
data analysis was complete.
Two identical, opaque spaniel plastic bowls (19 cm base
diameter, 11 cm rim diameter, 12 cm high, 8 cm deep) were used
to conceal the food treats. Spaniel bowls were selected for their
height and ability to conceal the treat from the dogs’ vision. Two
additional and identical spaniel bowls were placed underneath
the two testing bowls and treats identical to those used in the
experiment were hidden in the space between them. This method
was used by Udell et al. (2008a) and Oliva et al. (2015) to
ensure that both bowls smelled of the treats and the dog was
consequently not able to rely on olfaction when making its choice
between the bowls. The treats used were pieces of poultry and
vegetable flavored Frolic brand dry treats. Scores were marked by
the experimenter using pen and paper.
The PAQ (Zilcha-Mano et al., 2011) and EDED scale (Pageat,
1995) were completed using pen and paper. Dogs who obtain
an EDED score between 9 and 13 are classified as having
a “normal emotional state,” dogs with a score of 14–16 are
considered “phobic” and dogs scoring between 17 and 35 are
considered “anxious.” Dogs who receive a score beyond 35 are
classified as having a thymic or mood disorder (Pageat, 1995;
Pageat and Fatjó, 2013).
Procedure
The temporal unfolding of the overall procedure, comprising four
steps (phone interview, session 1, session 2, and session 3), is





Location Weight (kg) Time owned/in
care (years)
Pets Fostered M SD Male Female Spontaneous Non-
spontaneous
Inside Outside Both M SD M SD
Oxytocin 8 6 3.5 2.9 8 6 5 9 6 2 6 25.9 10 2.9 2.3
Placebo 8 8 3.1 2.9 9 7 5 11 7 2 7 25.9 12.2 2.3 2.7
DAP 9 7 2.3 2.3 9 7 5 11 5 3 8 27.6 6.4 1.6 1.5
Pets – – 4.9 3.0 17 8 8 17 10 4 11 22.8 11.7 3.8 2.8
Fostered – – 1.1 0.2 9 12 7 14 8 3 10 30.9 3.7 0.9 0.1
M = mean, SD = standard deviation.
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TABLE 2 | Breed differences between pet versus fostered dogs.
Origin of dogs
Pet dogs Fostered dogs
Breed N Breed N
Mixed 3 Bernese Mountain
dog × Labrador (St Pierre)
14
Border Collie 3 Labrador 6











Bernese Mountain Dog 1







Pinscher × Chihuahua 1
N = sample size.
described in Table 3. The different tasks described within the
steps’ procedure are detailed hereunder.
Stratification Test
The dogs participated in a “stratification test” to determine
their classification as “spontaneous point followers” or “non-
spontaneous point followers,” which would then inform their
semi-random allocation to a particular treatment group. The
setup of the stratification test consisted of three spots in a triangle
shape on the floor, marked by small pieces of blue tape, 145 cm
apart. The owner/puppy carer was asked to stand in the center of
the triangle, connected to their dog by a leash. The owner/carer
then randomly pointed five times at the spots, ensuring that each
spot was pointed at once, without pointing at the same spot two
times in a row. The behavioral veterinarian recorded how many
times the dog correctly approached the pointed at spot. Dogs that
followed their owner’s/puppy carer’s points correctly four or five
times, out of the possible five were classified as “spontaneous
point followers” while dogs that followed their owner’s/carer’s
points three times or less were classified as “non-spontaneous
point followers.”
Following the stratification test, and according to their
classification (spontaneous vs. non-spontaneous), their origin
(fostered dog vs. pet) and their sex, they were then allocated into
one of three treatment groups (DAP active and placebo = DAP,
DAP sham and placebo = control/placebo, DAP sham and
OT = OT) in a pseudo-randomized and counterbalanced way.
Point-following ability was included in the counterbalancing of
treatment groups so as not to have one group containing dogs
with more of a “spontaneous” point-following ability. This was
decided in line with previous reports of dogs exhibiting a wide
range of individual variability of OCTs.
Blood Drawing
Blood was taken in sessions 2 and 3 for subsequent measurements
of basal and “treatment-induced” OT and prolactin levels
respectively. Owners were asked to keep their dogs indoors the
night before both sessions 2 and 3 to minimize the effect of
ambient temperature on neurohormone secretion. Blood was
drawn by a veterinarian from the jugular vein or from the
cephalic vein, depending on the preference of the veterinarian
for the dog, with the help of an operator. Most of the time, the
TABLE 3 | Temporal unfolding of the procedure and actions performed in
each of its steps.
Procedure steps Time lapse Actions
Phone interview D0 Phone contact with the dog




Session 1 (S1) D1 Physical examination at the
Clinical Ethology and Animal






Allocation in one treatment
group
Session 2 (S2) D2 = D1 or any day in
between until at least
1 day before D3 [range




24–48 h before S3, fitting dogs
with the collar (follow-up phone
calls were made to ensure that
this was done at the correct
time)
Session 3 (S3) D3 = D1 + 47 days on
average [range of +1 to
+232 days (M = 47.17,
SD = 48.64)]
Food deprivation 6–8 h before
the OCT to enhance motivation
toward the treats
Intranasal administration of one
of the treatments (saline or OT)
Blood drawing 15 min after
treatment administration
PAQ completion, dog free to
explore the testing room
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dog was taken to a nearby room so that this was performed
in the absence of the owner/puppy carer. Dogs received a treat
immediately afterward in order to reduce stress responses. Up
to 8 ml of blood was collected into pre-chilled pink EDTA-
Aprotinin vacuum tubes (BD R© tubes, Elvetec, Pusignan, France)
and 1 ml into red vacuum tubes with gel separator (Vacuette R©
Greiner Bio-One, Alcyon, Paris, France), using either a 25G, 23G
or 21G needles, depending on the size of the dog. The pink
tubes were immediately transferred to an ice compartment where
they remained until centrifugation while red tubes remained at
room temperature for between 30 and 180 min. Samples were
centrifuged at 1,600 × g for 15 min at 4◦C. The plasma or serum
was then transferred to a plastic tube and stored at−20◦C.
Object Choice Task
Warm-up phase
The dog was first introduced to the bowls by the experimenter,
which each contained one treat. The experimental set-up was
similar to that of Virányi et al. (2008) and Oliva et al. (2015). The
two spaniel bowls were placed 1.5 m apart and the experimenter
knelt 30 cm behind the mid-point between the bowls. The dog
sat or stood in between its owner and an operator, restrained by
the operator by its collar, and faced the experimenter at a distance
of 2.5 m. The owner/puppy carer, although present in the room
at all times, did not participate in the task in any way, except in
some cases to initiate participation in the task, as described in
the scoring section below. The experimenter first got the dog’s
attention by calling its name. The dog was then shown a treat
before it was placed in one of the bowls in the dog’s full vision. The
experimenter then said the release word “va” (the French word for
“go,” or something equivalent if it was more familiar to the dog).
The operator then released the dog and allowed it to approach
one of the food bowls. If the dog approached the bowl containing
the treat, it was allowed to eat the treat before both bowls were
collected by the experimenter; if the dog approached the empty
bowl or the experimenter, they immediately collected both bowls
and the dog did not receive a treat. The warm-up phase consisted
of four trials regardless of the dog’s performance, so long as the
dog chose a bowl at least two out of the four trials. In cases where
the dog did not choose a bowl at least two out of the four trials,
the warm-up phase continued until two choices were made, or
the dog was excluded. Dogs were excluded after 10 min failing
to make two choices. After each trial, the experimenter stood
up with both bowls and walked to the side of the room which
was blocked from the dog’s vision by a barrier where they took
another treat in their hand, while the operator fetched the dog
and brought it back to the starting position. Once the dog was at
the starting position, the experimenter returned and placed the
bowls in their position on the floor and started the next trial.
Testing session
The experimental set-up was the same as in the warm-up phase.
The testing session comprised two blocks of fifteen trials (10
where a pointing cue was provided and five control trials in which
no cue to the treat’s whereabouts was provided). The control
condition was used to verify that the dogs were not relying on
scent to find the hidden food. Numerous studies have found that
performance is at chance level (Hare et al., 2002; Soproni et al.,
2002; Riedel et al., 2008; Udell et al., 2008a; Wobber et al., 2009;
Macchitella et al., 2017), or below chance level (Oliva et al., 2015)
when a control condition is employed. Each block comprised,
in sequence: three control trials, five trials with a momentary
distal pointing cue, two control trials and then another five trials
with a momentary distal pointing cue, in accordance with the
sequence in Oliva et al. (2015). Having only 15 trials per block was
strategically designed to keep the dog motivated. Furthermore,
the dog was allowed approximately 5 min break between testing
blocks to avoid burnout. Position of the correct bowl (left
or right) was predetermined according to the same pseudo-
randomized chart used in Oliva et al. (2015) that did not allow
more than two consecutive trials where food could be obtained
on the same side. As in the warm-up phase, after each trial, the
experimenter stood up with both bowls and walked to the side of
the room blocked from the dog’s vision by a barrier where they
baited one of the bowls, while the operator fetched the dog and
brought him/her back to the starting position. Once the dog was
at the starting position, the experimenter returned and placed the
bowls in their position on the floor and started the next trial.
Momentary distal point cue
The experimenter was kneeling, propped up on their toes, with
their arms by their side. They got the dog’s attention and then
rose their ipsilateral arm and pointed (using their index finger)
toward the correct bowl for 1–2 s, keeping their head straight,
before lowering their arm back down to their side and saying “va”
(or an alternative release word more familiar to the dog). The
approximate distance between the experimenter’s index finger
and the rim of the baited bowl was 42 and 50 cm to the treat
inside. The dog was then released and allowed to make a choice
between the bowls.
Control condition
The kneeling experimenter, propped up on their toes, got the
dog’s attention, kept their head straight for 1–2 s, then said “va”
(or an alternative release word) before the dog was released by the
operator and allowed to make a choice in the absence of any cue.
Scoring of the OCT
Scores were recorded as correct responses out of 10 trials per
block (20 per test). If the dog did not move within 5 s of being
released, the cue was given again by the experimenter. The dog
may also have been prompted once by the owner if instructed
to do so by the operator. If the dog did not approach a bowl
within 5 s, the score for that trial was “no choice.” “No choices”
were also recorded if the dog approached the experimenter
instead of a bowl.
Hormone Analysis
Prolactin was assayed in serum using the Prolactin canine ELISA
kit (Demeditec, Kiel, Germany) following the manufacturer’s
instructions. Plasma OT was assayed in the Oxytocin ELISA
kit from Cayman Chemical (Arbor Inn, MA, United States)
according to the manufacturer recommendations, including the
plasma solid-phase extraction. Szeto et al. (2011), McCullough
et al. (2013), and Christensen et al. (2014) have highlighted the
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crucial importance of carrying out this step, due to the fact that
studies which have been published using unextracted samples
have yielded levels far higher than extracted samples, leading to
discrepancies in findings. Because of OT levels inferior to the kit’s
sensitivity and in accordance with the manufacturer’s suggestion,
1.2 ml of plasma was first extracted on C18 columns (Hypersep
1 g, Thermo Fisher Scientific, Illkirch, France) followed by
elution in 98% acetone. After drying the samples by vacuum
centrifugation, they were resuspended in 0.6 ml assay buffer,
hence allowing a two times concentration factor. The available
plasma volumes of four samples in sessions 2 and 6 samples
in session 3 turned out to be too small to be assayed using
this method. The global procedure of extraction/concentration
and assay was first internally validated on seven Quality Control
samples of dog plasma from an external study to assess the
precision and the accuracy of the whole method through the
kit’s dynamic range: the mean precision was 12.0% and the
mean recovery was 98.3%. Of note, some of the authors have
recently published a validation of another Oxytocin ELISA kit
from Enzo Life Sciences (Bienboire-Frosini et al., 2017) to assay
OT in dog’s plasma. This kit was initially used in this study
but unfortunately lead to too many results under the limit of
detection. Therefore, we decided to use the Oxytocin ELISA kit
from Cayman Chemical with a lower limit of detection, such
as in MacLean et al. (2017).
Statistical Analysis
Data analysis was realized thanks to SAS 9.4 software
Copyright (©) 2002–2012 by SAS Institute Inc., Cary, NC,
United States. Bilateral situation; the significance threshold was
classically fixed at 5%.
Object Choice Task Performance
For the control conditions, correct attempts were totalled across
the two blocks to give a score out of a possible 10 for each dog.
Number of attempts made to the dog’s left bowl and the dog’s
right bowl were also calculated. For the cued conditions, correct
attempts for each of the testing blocks were combined to give
a total raw score out of 20 for each dog, as well as a score for
how many choices the dog made out of a possible 20. Then,
a percentage was calculated for each dog as to the number of
correct choices out of the total choices made. The same was done
for the control conditions, whereby correct attempts for each
block were combined to give a total raw score out of 10 for each
dog. The data set was visually inspected for missing data and data
entry accuracy. Two male pet dogs (1 entire, 1 neutered) were
too scared to approach the experimenter/bowls in the warm-up
phase of the OCT and so data pertaining to this part of the study
could not be obtained in these cases. Furthermore, an additional
3 neutered male pet dogs were not motivated enough by the food
(only by pets from the experimenter) to participate in the warm-
up phase of the OCT and so OCT data could not be obtained from
these dogs either. Hence the total sample size used in the analysis
of the OCT was 41 dogs.
Validation of the experimental set-up
Validation of the experimental set-up was determined by firstly
investigating side bias individually for each dog during the
control and cued trials, based on the number of times a dog
chose the right side and the number of times a dog chose the left
side compared to the proportion 50% using a binomial test using
the FREQ procedure. Secondly, validation of the experimental
set-up was determined by analyzing whether dogs collectively
performed the OCT above chance during the control trials
i.e., in the absence of a cue (chance is 50%). Only dogs who
made five or more bowl choices were included in this analysis,
extrapolating the logic of including only dogs that made 10
out of 20 choices for the cut-off in the control trials explained
below. Incidentally, after nine dogs were removed due to this
cut-off, all remaining dogs made six choices or more. A one
sample student t-test was realized using the TTEST procedure
for this analysis.
Object choice task outcomes
To test for the effect of treatment group on OCT performance,
two different outcomes were compared between the groups:
(i) the number of “no choices” made and (ii) the percentage
of correct choices made. Only dogs who chose 10 or more
times (out of a possible 20) were included in the analysis
pertaining to the second outcome. This was done because
we believe a percentage calculated for a binary outcome
(correct vs. incorrect), can be problematic because a certain
amount of trials are needed to show if the performance
is above chance level or not. For example, dogs who
made only one or two choices could accidentally perform
100% correct or 100% incorrect, but this would not be a
reliable reflection of their ability. Furthermore, using dogs
who made less than 10 choices also makes them difficult
to compare with previous studies which have generally used
averages from 10 or more trials (Miklósi et al., 1998, 2005;
Soproni et al., 2001; Udell et al., 2008b; Udell et al., 2010;
Gácsi et al., 2009; Oliva et al., 2015). Hence, 7 pet dogs
and 3 assistance dogs were excluded; 5 from the oxytocin
treatment group, 1 from the placebo treatment group and 4
from the DAP treatment group. However, before comparing
groups on the second outcome, we wanted to determine
whether dogs in each treatment group (OT, placebo, DAP)
and each recruitment group (pets and foster dogs) could
perform the OCT above chance levels (50%). For this
comparison, data analysis was performed by using a one
sample Student t-test realized with the UNIVARIATE procedure.
To compare performance between treatment groups, data
analysis was performed using a one-way ANOVA by using
the GLM procedure after testing that residuals were normal
(verified with the UNIVARIATE procedure) and variances were
homogeneous (verified with the GLM procedure). Post hoc
multiple comparisons were carried out using the LSMEANS
statement in PROC GLM using the Tukey-Kramer adjustment.
For the data pertaining to the percentage of correct choices, the
normality and the homoscedasticity of the data were verified,
and a parametric independent samples ANOVA was then
conducted. For the data pertaining to number of “no choices”
made, normality and homoscedasticity was tested and found to
be homogeneous between groups but not-normal. Hence, the
non-parametric Kruskal–Wallis test was performed using the
NPAR1WAY procedure.
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Neurohormonal Parameters
Comparison of plasma oxytocin levels between sessions and
treatment groups
To evaluate differences in plasma OT levels, plasma levels
between sessions and treatment groups were compared.
Conditions of normality and homogeneity of variances
were verified with the UNIVARIATE and GLM procedures,
respectively. Normality of data pertaining to plasma OT levels
were found to be normal. Homoscedasticity was found to
be verified. Given this, a General Linear Mixed Model was
conducted using the MIXED procedure to evaluate the main and
combined effects of treatment and session on OT levels.
Comparison of serum prolactin levels between sessions and
treatment groups
Data pertaining to serum prolactin levels were found to be non
normal. Other distributions were considered but were not found
to be appropriate. Therefore, data was box-cox transformed but
was still non normal after transformation. As such, only graphs
can be presented to depict differences between sessions and
treatment groups.
Comparison of serum prolactin levels according to origin
Average prolactin levels for each dog were calculated by
calculating the mean serum prolactin value obtained from
sessions 2 and 3. Data analysis was carried out in the
following way: assumption of normality was verified using the
UNIVARIATE procedure and homogeneity of variances using
the TTEST procedure. Prolactin levels in pet and foster dogs
were found to be skewed toward the lower range. An atypical
value was also obtained in the foster dog sample. Variances were
homogeneous, but due to the non normal distribution of the data
a non-parametric Wilcoxon two-sample test was done, using the
NPAR1WAY procedure, to compare levels between groups. The
analysis was performed with and without the atypical value and
it was not found to influence the results and hence, to maintain
the integrity of the data the results including the atypical value is
presented in the “Results” section.
Predicting Object Choice Task Performance
Backward deletion multiple regressions were conducted to
identify significant predictors of OCT performance on the two
outcome variables: (i) the number of “no choices” made and (ii)
the percentage of correct choices made. For the same reasons
described above in relation to the second outcome, only dogs who
chose a bowl 10 or more times were included in this multiple
regression analysis. Multiple regressions were realized for
qualitative explicative variables: dog gender (female entire/female
spayed/male entire/male neutered), origin (pet dog/fostered dog),
weight, home location (inside/outside/both), point-following
ability (spontaneous/non-spontaneous), session 3 plasma OT
levels, session 3 serum prolactin levels, owner avoidant
attachment scores, owner anxious attachment scores, EDED
scores, and treatment group (OT/DAP/placebo). Homogeneity of
variances was verified using the HOVTEST = LEVENE option
in the MEANS statement of GLM procedure. Normality was
verified on complete model residuals using the UNIVARIATE
procedure and the complete model was done using the GLM
procedure. After realizing the complete model, simplification
of this was done using backward selection method. The aim
of simplification was to find the best model for the data that
maximizes the r2 of the model. The GLMSELECT procedure
with the SELECTION = BACKWARD option on the MODEL
statement was used for this purpose. The selected model was
then studied using the GLM procedure. Data pertaining to
the percentage of correct choices was found to be normal and
homogeneity was also found between groups.
Comparison of Human Attachment
Avoidant and anxious attachment to dogs were compared for
pet owners and puppy carers. Data analysis was carried out in
the following way: conditions of normality and homogeneity
of variances was verified (with respectively the UNIVARIATE
procedure and the TTEST procedure). Normality of data
pertaining to owner/carer avoidant attachment scores toward
their pet dogs and their foster dogs was found to be skewed
toward the lower end in pet owners. Normality of data pertaining
to owner/carer anxious attachment scores toward their pet
dogs and their foster dogs was found to be skewed toward
the lower end in both groups. Variances between groups were
homogenous for both sub-scales but due to the non normal
distribution of scores non-parametric Wilcoxon two-sample tests
were employed to identify group differences.
RESULTS
Object Choice Task Performance
Validation of the Experimental Set-Up
Of the 41 dogs that were analyzed in the control trials, nine
demonstrated a significant side bias, representing 21.9% of the
population. Seven dogs (17% of the population) chose the bowl
to their left side significantly more than the bowl to their right
and two dogs (4.9% of the population) chose the bowl to their
right side significantly more than the bowl to their left (p< 0.05).
Of the 9 dogs, 6 were fostered dogs and 3 were pets, with 5/9
belonging to the OT group, 3/9 belonging to the DAP group and
1/9 belonging to the control group. Eight out of nine of these dogs
demonstrated a bias for the side where they experienced their
first food reward.
Of the 39 dogs that were analyzed in the cued trials (two dogs
did not make any choices in the cued trials), 10 demonstrated
a significant side bias, representing 25.6% of the population.
Seven dogs (17.9% of the population) chose the bowl to their
left side significantly more than the bowl to their right and three
dogs (7.7% of the population) chose the bowl to their right side
significantly more than the bowl to their left (p< 0.05). Of the 10
dogs, 8 were fostered dogs and 2 were pets, with 1/10 belonging
to the OT group, 5/10 belonging to the DAP group and 4/10
belonging to the control group. Seven out of ten of these dogs
demonstrated a bias for the side where they experienced their first
food reward. Interestingly, only three dogs with a left side bias in
the control trials also demonstrated the same left side bias in the
cued trials, and only one dog with a right side bias in the control
trials also demonstrated the same right side bias in the cued trials.
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One sample student’s t-test revealed the percentage of correct
choices in the control trials, where no cue was given to indicate
the location of the hidden treat, was not significantly different
from chance (50%) (M = 55.72, 95% CI [49.85; 61.59], SD = 16.27;
t = 1.99, p = 0.056), indicating that the dogs were performing at
chance levels in the absence of a cue.
Outcome 1: Number of “No Choices” Made
Table 4 shows the average number of times dogs in each
treatment group did not make a choice following a given cue and
in the absence of any cues (control trials).
A Kruskal–Wallis test revealed a non-significant effect of
treatment group on number of “no choices” made for trials where
a cue was provided, X2 (2, N = 41) = 1.96, p = 0.374.
Outcome 2: Percentage of Correct Choices Made
Table 5 shows the percentage of correct choices made by the
whole population of dogs in the sample.
On the whole population, the highest mean percentage
of correct choices and the lowest standard deviation are
interestingly both obtained for the DAP group. Indeed, the
standard deviations are quite large, particularly for the OT group.
This is not surprising given that some of these dogs only chose a
very small number of times, or in two cases, made “no choices” at
all (refer to scores in Table 4) thereby obtaining a percentage of
correctness that was based on 0–2 trials only (see Table 6 for raw
scores). Therefore, based on the logic explained in the “Statistical
Analysis” section, it was decided to only include dogs that chose
10 times or more for inclusion in the ANOVAs in the following
section. Tables 6 and 7 show the pattern of performance of the
dogs that chose at least once but less than 10 times and were
therefore excluded from the ANOVAs.
What is immediately striking from Table 6 is that none of the
numerators are equal to the denominators, meaning that all these
eight dogs experienced failure at some point during the task. The
dogs in the OT group comprised 3 pet dogs and 1 foster dog while
the DAP group comprised 2 pet dogs and 2 foster dogs, so origin
does not appear to influence why these dogs made so few choices.
To further investigate why some dogs might have stopped making
choices, we looked at the rates of success or failure of the previous
attempt before the dogs decided to stop. This was done for all
dogs who started the OCT and either stopped completely (did
not make any further attempts) or stopped and then started
again, including both the control trials (10) and the cued (i.e.,
pointing) trials (20).
As can be seen from Table 7, almost half the dogs that
made less than 30 attempts on the OCT started the task (which
began with a control, i.e., un-cued trial) by not making a choice.
Furthermore, dogs in all treatment groups stopped participating
(i.e., did not participate in at least the next trial) more often
after a failed attempt than after a successful one. This may
suggest that their prior success (or failure) is influencing their
decision to make a future attempt. Non-participation included
anything that did not involve making a selection between the
two bowls, so non-participation also included approaching the
experimenter. While not considered participation in the task
per se, this could still have been considered by the dogs as
a potential strategy to obtain food. To investigate whether
dogs were using this strategy more or less in a particular
treatment group, percentages were calculated indicating how
often this approach was used during a “stopping event” (refer
to Table 7). By eye-balling these percentages, it appears that
the OT group used this non-rewarding technique less than the
other two groups.
Compared to chance
One samples t-tests were used to compare whether dogs in each
treatment group and each recruitment group could perform the
OCT significantly better than chance. As explained above, only
dogs who chose 10 or more times were included in this analysis.
Percentage of correct choices made were compared to the chance
level of 50%. Dogs in all groups were found to perform the OCT
above chance, as can be seen in Table 8.
TABLE 4 | Mean and median number of times dogs in each treatment group did not make a choice in the cued trials (out of 20) and in the control trials (out of 10).
Type of trial Group N M SD Lower 95% CI Upper 95% CI Median Lower quartile Upper quartile Min Max
Cued Oxytocin 13 7.69 9.22 2.12 13.27 2 0 18 0 20
Placebo 13 2.62 5.69 −0.83 6.06 0 0 2 0 20
DAP 15 5.27 6.88 1.46 9.08 1 0 1.46 0 18
Control Oxytocin 13 3.23 3.49 1.12 5.34 1 0 7 0 8
Placebo 13 1.54 2.47 0.05 3.03 1 0 2 0 9
DAP 15 2.93 3.08 1.23 4.64 2 1 4 0 9
N = sample size, M = mean, SD = standard deviation, CI = confidence interval.
TABLE 5 | Mean percentage of correct choices made by all dogs in each treatment group.
Group N M (%) SD (%) Lower 95% CI Upper 95% CI Min (%) Max (%)
Oxytocin 12 58.87 38.99 34.09 83.64 0 100
Placebo 13 57.05 22.74 43.31 70.79 0 90
DAP 15 63.15 16.28 54.14 72.17 33.33 94.12
N = sample size, M = mean, SD = standard deviation, CI = confidence interval.
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TABLE 6 | Raw correct scores (out of total choices made by dog) for dogs that












Average number of attempts 1.5 4.75
∗Pet dog, †fostered dog.
Comparison between treatment groups
An independent samples ANOVA revealed that there was a
significant effect of treatment group (DF = 2, F = 4, p = 0.030).
Post hoc multiple comparisons revealed that dogs that received
OT chose the correct bowl significantly more than dogs in the
control condition (Tukey, p = 0.0248). No other significant
differences were found between groups.
Neurohormonal Parameters
Comparison of Plasma Oxytocin Levels Between
Sessions and Treatment Groups
Mean levels of plasma OT according to session (2 or 3) and
treatment (OT, DAP or saline) can be seen in Table 9, as well as
mean levels of plasma OT according to session only (including
a combination of dogs from each treatment group). A mixed
model ANOVA revealed a significant main effect of session
(DF = 1, F = 5.36, p = 0.025), an insignificant main effect of
treatment DF = 2, F = 0.92, p = 0.408) and an insignificant
session × treatment interaction DF = 2, F = 2.13, p = 0.130).
These findings indicate that plasma OT levels were significantly
higher in session 2 than in session 3 in the whole dog population,
regardless of the treatment given to dogs.
Comparison of Mean Serum Prolactin Levels
Between Sessions and Treatment Groups
Mean concentrations of serum prolactin between sessions and
between treatments are shown in Figure 1. Visual inspection of
Figure 1 suggests no differences between sessions, or treatment
groups as the error bars all overlap.
FIGURE 1 | Mean concentration (ng/ml) of dog serum prolactin and standard
error according to treatments and sessions.
Comparison of Serum Prolactin Levels According to
Origin
Levels of serum prolactin for session 2 and session 3 were
averaged for each animal independently. The median of these
values were then calculated for pet dogs and foster dogs
separately, and are presented in Table 10.
A two-sample Wilcoxon Test showed that foster dogs had
significantly higher levels of serum prolactin compared to pet
dogs, Z (N = 46) = 2.27, p = 0.024.
Predicting Object Choice Task
Performance
Predictors of OCT performance were evaluated separately
for the two outcome variables: (i) total “no choices” and
(ii) percentage of correct choices made. Backward deletion
multiple regressions were conducted for the two separate
outcomes variables using the following predictor variables:
dog gender (female entire/female spayed/male entire/male
neutered), origin (pet dog/fostered dog), weight, home location
(inside/outside/both), point-following ability (spontaneous/non-
spontaneous), session 3 plasma OT levels, session 3 serum
prolactin levels, owner avoidant attachment scores, owner
anxious attachment scores, EDED scores, and treatment group
(OT/DAP/placebo). Means and standard deviations for the
TABLE 7 | Total number of dogs who made less than the total number of attempts set in the test (i.e., <30), the percentage of these dogs that started the OCT with a
“No Choice”, the total number of stopping events after successes and failures, and the percentage of these dogs who approached the experimenter at least once during
their “Stopping Event.”
Group N % started with
“no choice”
Average number of
choices not made in
control trials (out of 10)
Average number of
choices not made in







Average % of times dogs
approached experimenter
as their “no choice”
Oxytocin 7 57.14 5.71 14.29 5 12 22.39
Placebo 5 40 3.20 7 3 8 36.55
DAP 9 44.44 4.44 8.78 9 16 39.26
Total 21 47.62 4.57 10.19 17 36 33.70
N = sample size.
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TABLE 8 | Mean percentage of correct choices made by dogs (that chose 10 or more times) in each treatment and recruitment group compared to chance (50%).
Group N M (%) SD (%) Lower 95% CI Upper 95% CI Min (%) Max (%) t statistic p-value
Oxytocin 8 82.05 16.70 68.09 96.01 50 100 5.43 0.001
Placebo 12 61.80 15.60 51.89 71.71 35 90 2.62 0.024
DAP 11 67.03 15.69 56.49 77.56 47.37 94.12 3.60 0.005
Pet 13 75.32 17.49 64.75 85.88 50 100 5.22 0.0002
Fostered 18 64.23 16.30 56.13 72.34 35 90 3.70 0.0018
N = sample size, M = mean, SD = standard deviation, CI = confidence interval.
TABLE 9 | Mean concentration of plasma oxytocin (pg/ml) in each session and in
each treatment group separated by session.






2 40 29.27∗ 14.07 24.77 33.77 5.43 66.54
3 38 22.71∗ 13.29 18.34 27.08 5.09 56.60
Group and session
Oxytocin S2 12 30.64 18.73 18.74 42.54 5.43 66.54
Oxytocin S3 12 27.17 16.55 16.66 37.68 5.09 56.60
Placebo S2 12 23.45 8.38 18.12 28.77 12.66 39.89
Placebo S3 11 21.44 13.57 12.32 30.56 7.89 50.23
DAP S2 16 32.61 12.86 25.76 39.46 14.20 53.56
DAP S3 15 20.08 9.71 14.70 25.46 8.26 35.31
S = session, N = sample size, M = mean, SD = standard deviation, CI = confidence
interval. ∗p = 0.025.
categorical variables “gender,” “origin,” “home location,” and
“point-following ability” included in the analyses are shown in
Table 11. Refer to Table 8 for this information pertaining to
treatment group.
For total “no choices”, the model containing all the predictors
was non-significant. Variables were removed from the model
following a backward selection in the following steps: (i)
gender, (ii) home location, (iii) treatment group, (iv) avoidant
attachment scores, (v) weight, (vi) session 3 plasma OT levels,
(vii) session 3 serum prolactin levels, (viii) anxious attachment
scores, (ix) EDED scores, and (x) point-following ability. Step 10
resulted in the greatest improvement of the model and reached
significance, DF = 1, F = 11.93, p = 0.0015, r2 = 0.27, with
“origin” explaining 27% of the variance in “no choice” scores.
Regression coefficients for the significant model can be found
in Table 12.
Because the significant variable left in the model was
categorical, an independent samples ANOVA was then run to
further study the selected model coming from the backward
selection procedure, (i.e., using only the “origin” variable which
was the significant predictor for “no choice” outcomes). The
ANOVA revealed that pet dogs were significantly more likely not
to make a choice than foster dogs, DF = 1, F = 5.23, p = 0.028.
For percentage of correct choices made, the model containing
all the predictors was non-significant. Variables were removed
from the model following a backward selection in the following
steps: (i) gender, (ii) home location, (iii) anxious attachment
scores, (iv) session 3 plasma oxytocin, (v) EDED scores, (vi)
avoidant attachment scores, (vii) weight, (viii) session 3 serum
prolactin, and (ix) origin. Step 9 resulted in the greatest
improvement of the model and reached significance, DF = 3,
F = 3.89, p = 0.022, r2 = 0.34, with “point-following ability” and
“treatment” explaining 34% of the variance in percentage correct
scores. Regression coefficients for the significant model can be
found in Table 13.
Because the significant variables left in the model were
categorical, a two-factor ANOVA was then run to further
study the selected model coming from the backward selection
procedure, (i.e., using only “treatment group” and “point-
following ability” as independent variables). In line with the
previously presented independent samples ANOVA, the two-
factor ANOVA revealed that percentage of correct choices made
was significantly different according to “treatment group,” DF = 2,
F = 4.86, p = 0.016, and post hoc multiple comparisons revealed
that dogs who were in the “OT” group were more likely to choose
correctly than dogs in the “placebo” group (Tukey, p = 0.014).
A trend was also observed for “point following ability” whereby
spontaneous dogs were more likely to choose correctly than
non-spontaneous dogs, DF = 1, F = 3.82, p = 0.061.
Comparison of Human Attachment
The range, and median scores for pet owner and puppy carer
anxious and avoidant attachment scores can be seen in Table 14.
For avoidant attachment scores, a two-sample Wilcoxon Test
showed that puppy carers were significantly more avoidantly
attached than pet owners, Z (N = 46) = 3.03, p = 0.0024.
TABLE 10 | Serum prolactin levels (ng/ml) in pet dogs versus foster dogs.









Pet dogs 25 6.05 8.84 2.31 9.78 2.17∗ 1.225 8.721 0.20 40.47
Foster dogs 21 14.73 17.43 6.79 22.67 8.39∗ 3.214 18.810 0.20 68.81
N = sample size, M = mean, SD = standard deviation. ∗p < 0.025.
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TABLE 11 | Means and standard deviations for the categorical variables “Gender,”
“Origin,” “Home Location,” and “Point-Following Ability” included in the multiple
regression analyses.
Total “no choice” % Correct
N M SD N M SD
Gender
Female entire 4 3.50 3.32 4 63.75 16.19
Female spayed 16 4.31 7.37 12 66.41 17.30
Male entire 3 6 10.39 2 57.50 10.61
Male neutered 18 6.22 8.16 13 74.49 18.48
Origin
Pet 20 7.80 8.20 13 75.32 17.49
Fostered 21 2.71 5.91 18 64.23 16.30
Home location
Inside 15 4.73 7.92 11 65.19 19.42
Outside 21 5.86 7.60 16 69.45 16.27
Both 5 3.80 6.38 4 76.75 17.99
Point-following ability
Spontaneous 13 5 7.68 10 75.62 18.10
Non-spontaneous 28 5.29 7.53 21 65.67 16.58
N = sample size, M = mean, SD = standard deviation.
TABLE 12 | Standardized and unstandardized regression coefficients for each
predictor in the significant model of the backward deletion multiple regression for
“no choice” outcome.
Parameter B β SE
Intercept 8.71 0 1.55
Fostered −7.48∗ −0.15∗ 2.17
Pet 0 0 –
B = standardized regression coefficient, β = unstandardized regression coefficient,
SE = standard error. ∗p = 0.0015, r2 = 0.27.
TABLE 13 | Standardized and unstandardized regression coefficients for each
predictor in the significant model of the backward deletion multiple regression for
percentage correct outcome.
Parameter B β SE
Intercept 75.88 0 5.90
Spontaneous 0 0 –
Non-spontaneous −13.91∗ −0.40∗ 6
Oxytocin 13.54† 0.35† 7.24
Placebo −7.42 −0.21 6.73
DAP 0 0 –
B = standardized regression coefficient, β = unstandardized regression coefficient,
SE = standard error. ∗p = 0.03, †p = 0.07, r2 = 0.34.
For anxious attachment scores, no significant differences were
observed between groups analyzed with a two-sample Wilcoxon
Test, Z (N = 46) = 0.30, p = 0.77.
DISCUSSION
This study aimed to further previous findings demonstrating
that intranasal OT enhances dogs’ performance on an OCT
(Oliva et al., 2015; Macchitella et al., 2017) by comparing the
effects of OT and DAP on (i) number of choices made on
an OCT and (ii) correctness of choices made on an OCT,
when compared to placebo. The study also aimed to investigate
the effects of dog gender (female entire/female spayed/male
entire/male neutered), origin (pet dog/fostered dog), weight,
home location (inside/outside/both), point-following ability
(spontaneous/non-spontaneous), session 3 plasma OT levels,
session 3 serum prolactin levels, owner avoidant attachment
scores, owner anxious attachment scores, EDED scores, and
treatment group (OT/DAP/placebo), on OCT performance.
Finally, the study aimed to identify differences in pet owner
versus puppy carer attachment, as well as pet versus foster dog
prolactin levels.
OCT Performance Compared to Chance
In line with previous findings (Oliva et al., 2015), all dogs that
made more than 10 choices on the OCT were able to perform
above chance. However, the difference in scoring between the two
studies meant that more dogs in the current study made less than
10 choices. Indeed, when a dog did not make a choice in Oliva
et al.’s study it was given a test of motivation, which involved
two pre-training trials (one to each side). If the dog chose a bowl
during this test of motivation, it was deemed to be motivated
and thus an assumption was made that the previous “no choice”
outcome was due to the dog not understanding the task and so
was given a score of “incorrect choice” for that trial. In contrast,
in the current study, the task purposely continued without a test
of motivation, and a score of “no choice” was given to that trial.
Another important difference in the study by Oliva et al. is that
only two dogs did not pass the initial pre-training, in which the
dog had to select the correct bowl four times in a row after being
shown the treats being placed into the correct bowl. Inspection of
Oliva et al.’s (unpublished) raw data revealed that, surprisingly,
42% of the 67 dogs who completed the initial pre-training needed
more than four attempts to complete the initial pre-training,
with 15% needing 10 or more trials. Furthermore, pre-training
was repeated before each block, of which there were four per
TABLE 14 | Avoidant and anxious attachment scores in pet owners and puppy carers.









Pet owner avoidant 25 1.57 0.61 1.32 1.82 1.20∗ 1.20 1.70 1 3.40
Puppy carer avoidant 21 2.08 0.67 1.77 2.38 1.90∗ 1.60 2.30 1.20 3.60
Pet owner anxious 25 2.34 0.99 1.93 2.74 2 1.60 2.70 1.20 4.80
Puppy carer anxious 21 2.42 0.92 2 2.84 2.20 1.60 3.30 1.40 4
N = sample size, M = mean, SD = standard deviation. ∗p < 0.0025.
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testing session. While the number of dogs needing more than
four attempts per session reduced over the blocks within each
session, the number of dogs requiring more than four attempts
for the initial pre-training before session two rose back up to 52%,
however only 3 out of 63 dogs who completed session 2 needed
10 or more attempts. Therefore, it is fair to say that the dogs in
Oliva et al.’s study received a lot more pre-training compared to
the dogs in the current study which were given four trials only,
regardless of the dog’s performance, so long as the dog chose a
bowl at least two out of the four trials. The reduced pre-training
in the current study was a purposeful attempt to reduce the
probability of dogs learning how to perform the task within the
sessions, as was observed in Oliva et al. (2015). Still, the reduced
pre-training in the current study did not appear to affect dogs’
ability to perform above chance, in dogs that were willing to make
more than 10 choices. It may, however, have reduced the number
of dogs willing to make 10 choices.
The Influence of Oxytocin Versus DAP on
OCT Performance
The hypothesis that OCT performance would be enhanced by
both OT and DAP compared to placebo was only partially
supported as the percentage of correct choices made in the
OCT was enhanced by OT compared to placebo, but not DAP
compared to placebo, in the sub-population of dogs who made
at least 10 choices. These performance enhancing effects of OT
are in line with previous studies (Oliva et al., 2015; Macchitella
et al., 2017). In the current study we investigated performance
in two ways (i) number of choices not made (based on the
whole sample) and (ii) percentage of correct choices out of
those made (based on the sample of dogs that made 10 or
more choices, i.e., the “best choosers”). Our findings suggest
that OT increases the percentage of correct choices made in the
“best choosers” sub-population but not the number of choices
made. This is an important finding, as previously it has been
put forward that perhaps dogs are performing better due to a
decrease in anxiety when performing the task (Oliva et al., 2015),
however, the current findings do not suggest a willingness to
“have a go” is the reason why dogs are performing better, as
OT did not increase number of choices made. In fact, for the
eight dogs that made at least one but less than 10 attempts
when given the pointing cue, the four dogs belonging to the
OT group demonstrated very low rates of choosing (1.5 choices
on average) compared to the other four dogs belonging to
the DAP group (who chose 4.75 times on average) (refer to
Table 6). To investigate why this might be we looked at the
sub-group of dogs (N = 21) who made less than 30 attempts
(on both the control and cued trials) which revealed that
dogs in all groups were more likely to stop performing the
OCT (i.e., not participate in at least the following trial) after
a failure than after a success (refer to Table 7). Hence, the
very low number of attempts (<10) seen in the OT group
may suggest that this group were more influenced by prior
losses than the dogs in the DAP group. The reverse of this
(i.e., being influenced by prior success) may have also been
taking place in dogs who demonstrated a side bias, with the
majority of these dogs developing a bias to the side where
they first experienced a food reward. Interestingly, dogs in the
OT group made up the majority of these dogs in the control
trials at 56%, but reduced to the minority group in the cued
trials at 10%, which may suggest that these dogs employed
different techniques on the OCT, depending on whether a
cue was offered or not. The OT group also contained the
largest percentage of dogs who started the OCT (which always
commenced with a control/no cue condition) by not choosing.
It is possible that these dogs realized from the very beginning
that they did not understand the task, or were being tricked
that they had enough information to complete it correctly, and
therefore made a beneficial decision to not perform – after all,
if they don’t perform, they can’t be wrong. They also used
the non-reinforcing strategy of approaching the experimenter
(which resulted in the experimenter immediately picking up the
bowls and walking away), less times than the other two groups.
This may reflect a greater understanding in these dogs that
this strategy would not result in a reward, food or otherwise,
when performing this task, despite the fact that they might
use this strategy to obtain food or attention from humans
outside of the task. DAP has been shown to have effects as
an emotional modulator in dogs (Sheppard and Mills, 2003;
Gaultier et al., 2005, 2008; Tod et al., 2005; Mills et al., 2006;
Denenberg and Landsberg, 2008; Kim et al., 2010; Siracusa
et al., 2010; Landsberg et al., 2015). In this study, it did not
significantly increase number of “no choices” made nor OCT
performance in the “best choosers” population. However, it is
noteworthy that on the whole population descriptive data, the
DAP group displayed the lowest standard deviations/variability,
suggesting a greater homogeneity in OCT performance for this
group. This could be related to the general ability of appeasing
pheromones in modulating/smoothing the cognitive-emotional
responses among individuals, particularly in the context of
cognitive tasks, as already described in horses treated with
EAP (Equine Appeasing Pheromone, the homologous specific
appeasing pheromone) by Mengoli et al. (2014). It could be
possible that the “best choosers” dogs were already in this kind
of balanced cognitive-emotional state, hence making us unable to
conclude about DAP effects in this population.
An alternative explanation for the reduced choosing behavior
observed in dogs treated with OT is that the putative
“relaxing” effect of OT (Uvnas-Moberg and Petersson, 2005)
may have caused them not to care to participate in the
OCT since they were already in a kind of “rewarded” mental
state of well-being and so did not need to work further
to get a reward (refer to Table 7). It is also possible that
the anorexigenic effects of OT impacted their motivation to
perform a task where their efforts are rewarded by food
(see reviews, Olszewski et al., 2010; Onaka et al., 2012;
Spetter and Hallschmid, 2017).
The Influence of Intranasal Oxytocin on
Neurohormonal Parameters
The hypothesis that plasma levels of OT and serum prolactin
will change following DAP and OT exposure was not supported.
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Treatment was not found to have any effect on plasma OT or
serum prolactin levels. However, dogs in the OT treatment group
demonstrated enhanced cognitive ability and so in relation to
the modality of intranasal OT, our findings suggest that OT
delivered intranasally reaches the brain directly, and not by a
peripheral mechanism, as has been postulated (Lee et al., 2018).
These findings are also discrepant with previous findings in dogs
where an increase in levels of OT has been reported 15 min after
intranasal application (Romero et al., 2014; Temesi et al., 2017).
There are several reasons why our findings are discrepant with
Romero et al. (2014). First, in their study 40 IU of intranasal
OT was applied, vs. 24 IU used in the current study. As this is
nearly double the amount, this could go some way to explaining
the differences in findings between our study and theirs. Second,
the number of dogs in their study was only five, compared to
the 12 dogs that we were able to analyse in the OT treatment
group. In addition to this larger sample size, we also observed a
high rate of variability in our population, as evidenced in Table 9,
which could have “hidden” any possible difference between the
sessions and/or groups. Such wide variability in OT levels in
plasma is not uncommon after intranasal administration and
has also been reported in monkeys for instance (Lee et al.,
2018). Indeed, a variability of approximately 50% of mean
basal plasma OT concentrations has been previously reported
within populations from several species, regardless of exogenous
OT administration (Bienboire-Frosini et al., 2017). Crockford
et al. (2014) precisely described and explicated the general
variability of the oxytocinergic system within species. Third,
the discrepancies could be due to differences in measurement
procedures. For example, Romero et al. used radioimmunoassay
(RIA) to assay OT in plasma, whereby the current study used
EIA. With regards to Temesi et al. (2017) again, a small
number of only six dogs was analyzed, and their methods to
measure OT also differed from ours in an important way.
For instance, they assayed OT in serum, not in plasma, and
used a different ELISA kit, which has not been validated for
use in dogs, to the best of our knowledge. Furthermore, the
levels of OT they found after intranasal application (of 12
IU) is much higher than the one observed by Romero et al.
with 40 IU intranasal application. Still, our lack of an OT
increase in the blood is also inconsistent with findings from
previous studies in rodents (Neumann et al., 2013), but may
be explained by the fact that these changes take longer than
15 min to reach the blood. Indeed, Neumann et al. (2013)
only observed a significant increase in blood 70 min following
intranasal administration. This suggests that the OT first reaches
the brain where it has measurable behavioral consequences
and this may result in a downstream increase in the OT in
the blood after 15 min. Conversely, other studies in primates
and humans have showed that plasma OT could peak at 10–
15 min after the intranasal administration (Striepens et al.,
2013; Dal Monte et al., 2014). Future studies would need to
be conducted to investigate this in dogs, using large samples
and validated methods to measure OT in blood. Similar effects
may also be observed in serum prolactin and future studies
should take additional blood samples at various times to attempt
to capture this.
Interestingly, in the current study, plasma OT levels
significantly decreased from session 2 to session 3 in the whole
population, with no influence of treatment, refer to Table 9.
We can speculate that this decrease in OT between sessions
reflects the dogs being less stressed/aroused during session
3. Indeed, previous authors showed that OT release in brain
and plasma could be related to acute stress events (Wotjak
et al., 1998; Onaka et al., 2012; Noller et al., 2013). Despite
the veterinarians’ attempts to reduce the stressfulness of the
first blood sampling, it is possible that this handling could
still trigger an increase in endogenous plasma OT levels to
dampen the HPA axis activation, as already observed in mini-
pigs (Marcet Rius et al., 2018) and beef heifers (Wagner et al.,
2019). In session 3, the dogs would have been more familiar
with the veterinarians and the testing location and therefore
may have felt more comfortable with the environment. The
opposite possibility is also true that they may have formed a
negative association with the veterinarians due to the blood
sampling. However, for the dogs that received OT intranasally
in session 3, this may have acted as an anxiolytic as it has been
successfully demonstrated in humans (Heinrichs et al., 2003;
de Oliveira et al., 2012). Similarly, for the dogs that received
DAP, this too may have acted as an emotional modulator as
has been previously demonstrated (Sheppard and Mills, 2003;
Gaultier et al., 2005, 2008; Tod et al., 2005; Mills et al., 2006;
Denenberg and Landsberg, 2008; Kim et al., 2010; Siracusa
et al., 2010; Landsberg et al., 2015). Alternative methods have
shown promise in more accurately measuring total (bound and
unbound) levels of OT, the bound fraction of which needs to
be unbound before being measured (Brandtzaeg et al., 2016).
Future studies may consider the use of these methods in
assessing whether bound levels of OT have an effect on OCT
performance in dogs.
Predicting OCT Performance
Contrary to our expectations, plasma OT levels did not differ
in better performing dogs. In addition to our expectation that
dogs with higher levels of plasma OT levels would perform
better on the OCT, we also expected better performing dogs
to be more likely to be male and to be pets, while higher
levels of prolactin and EDED scores to be present in the poorer
performing dogs. Our findings that gender did not predict
performance are in contrast to Oliva et al.’s (2015) findings of
an enhanced performance in male dogs compared to female
dogs following intranasal saline administration, however, they
are in line with their findings that gender no longer acted
as a predictor following intranasal oxytocin administration.
This may be explained by the significant treatment effect
observed in our study. Interestingly, foster dogs were more
likely to make a choice than pet dogs, but they were no more
likely than pet dogs to choose correctly, refer to Tables 12,
13. This highlights an important point that just because the
dog is performing, does not indicate that it has a better
understanding of how to perform than a dog that chooses
not to. Furthermore, foster dogs’ increased choosing behavior
may not reflect greater willingness to have a go, but may be
more reflective of their training and familiarity with following
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orders, compared to pet dogs. Alternatively, this could reflect
a change in the wiring of these dogs’ brains, due to their
particular upbringing. Previous studies have identified individual
differences in OCT performance (Miklósi et al., 1998; Agnetta
et al., 2000; Hare et al., 2002; Udell et al., 2008a,b; Udell
et al., 2010; Virányi et al., 2008; Wobber et al., 2009; Oliva
et al., 2016b). Oliva et al. (2016b) investigated whether this
could have been due to differences in the OT receptor gene
but were not able to demonstrate an association. Findings
from the current study suggest that a dogs’ early social and
learning experiences may impact their ability to use human social
gestures effectively, and this may be more influential than their
genetic blueprint.
Human Attachment to Pet Versus Foster
Dogs
In addition to having increased serum prolactin levels (refer
to Table 10), foster dogs had carers with greater avoidant
attachment toward them, compared to pet dog owners, in
line with our hypothesis, refer to Table 14. We consider
this to be one of the most important findings of this study
because it highlights that foster dogs are being brought up by
carers who are possibly reluctant to form a close attachment
towards them. This is not surprising given that carers know
they will eventually have to give the dogs away and so is
a logical emotional defense mechanism. Avoidant attachment
styles may require the dog to be more flexible from an emotional
point of view and might adversely affect its development and
ability to cope with subsequent rehoming experiences, which
the dogs in the current study were yet to experience. Konok
et al. (2015) has already demonstrated that avoidant styles of
adult attachment have been associated with owning dogs with
separation related disorders. While the dogs in the current
study were not showing symptoms of emotional dysregulation,
this could be a potentially important problem in assistance
dogs given they are bred to be confident and calm. As,
while they may have a natural propensity to be so, if their
environment is not conducive to the development of these
characteristics then consideration needs to be given as to how
their environment can be enhanced and improved for their
welfare and for the welfare of the humans that they are born to
lead and assist.
Limitations and Future Directions
Limitations of the present study include the uncontrolled hunger
levels between subjects which may have affected motivation to
perform the OCT. We tried to control for this by instructing
owners/carers not to feed their dogs for 6–8 h before testing
but it is possible that these instructions were not adhered to
by all participating owners/carers, or that food rewards were
simply not motivating enough for some dogs. Interestingly,
foster dogs made more choices on the task than pet dogs
and we cannot rule out the possibility that this might be due
to the fact these dogs were more motivated by food than
pet dogs simply because they comprised of breeds known to
be more motivated by food, refer to Table 2, (Raffan et al.,
2015). Hence, future studies wishing to compare assistance dogs
with pet dogs should use pet dogs of the same or similar
breeds. Another limitation was the set-up of the room which
was not 100% symmetrical – the food was placed into the
bowls behind a black screen on the dog’s left-hand side – the
same side the majority of dogs with a side bias showed an
overall preference for when choosing bowls. However, dogs
with a significant side bias only represented a minority of
the population, with 21.9% in the control trials and 25.6%
in the cued trials. Collectively, in the control condition, all
dogs (with and without a significant side bias) performed at
chance level, which validates the experimental set-up in that they
were not able to use the sense of smell to find the food, nor
were they being influenced by potential subconscious “Clever
Hans” effects (Pfungst, 1911) from the experimenter providing
the cues. This relates to the importance of having a “blind”
experimenter, a strength of the current study, so they are unable
to unintentionally influence the dog’s choices according to their
treatment allocation. Lastly, we chose to be consistent with the
timing and dose of Oliva et al.’s (2015) previous study, however,
it is currently unknown what constitutes the optimal behavioral
testing time after administration of OT in dogs, and how long
the behavioral effects last. However, extrapolating from the
findings of a human study investigating CSF following intranasal
application of 40 IU and 80 IU of the very similar peptide,
vasopressin (Born et al., 2002), and a pig study investigating
CSF following intranasal application of 24 IU of OT (Rault,
2016), we can reasonably assume that OT is still active in the
brain 100–120 min after administration, and potentially longer.
Therefore, the cognitive effects in the current study were likely
to have been maintained for the entire OCT, which normally
lasted between 30 and 45 min, or 75 and 90 min post intranasal
administration. Lastly, our final sample size for the percentage
of correct choices made was reduced due to the exclusion of
dogs that made less than 10 choices for this analysis, due
to the interesting finding that a number of dogs chose less
than 10 times. Therefore, future studies that plan to employ
a similar low level of pre-training as the current study may
wish to increase the number of dogs in their sample to account
for this attrition.
CONCLUSION
The current study replicated previous findings that intranasal
OT enhances performance on an OCT in a population of dogs
that made more than 10 choices. The study furthered these
findings by demonstrating that this enhanced performance is
relevant to percentage correctness and not number of choices
made. Furthermore, this study revealed that DAP does not have
the same performance-enhancing effects. Findings that plasma
OT does not increase 15 min following intranasal application
of OT supports the notion that OT gains direct access to the
brain, bypassing the bloodstream when administered intranasally
in dogs. Neither plasma OT levels, nor serum prolactin levels
were found to predict OCT performance, however, serum
prolactin was found to be higher in foster dogs compared
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to pet dogs. Additionally, fostered dogs were more likely to
perform in the OCT in terms of making a choice, but these
choices were not any more likely to be correct. Fostered dogs
were also more likely to be cared for by humans with an
avoidant attachment toward them. These findings highlight
important considerations for current assistance dog foster and
training situations.
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